newsfilter
← Latest News
Business Wire·

ImmunoPrecise Announces AI-Driven Breakthrough in Universal Dengue Vaccine Discovery

LENSai™ powered by HYFT® technology Identifies a single multi-factorial target conserved across all dengue serotypes. ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ:IPA) a leader in AI-driven biotherapeutics,